Mass. Movers

Drug developer reports loss, debt facility


Infinity Pharmaceuticals cut its fourth-quarter net loss to $32.9 million, or 68 cents per share, compared with $46.9 million, or $1.15 per share, a year earlier. The Cambridge-based company said its full-year net loss was $126.7 million, or $2.64 per share, compared with $53.9 million, or $1.70, the previous year. It also said it entered into an agreement with affiliates of Deerfield Management Co., a health care investment organization and Infinity shareholder, to provide a $100 million debt facility.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of